Clinical Trials Directory

Trials / Completed

CompletedNCT02738736

Clarifying Optimal Sodium Intake Project

Clarifying Optimal Sodium Intake Project- Objective 1

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
269 (actual)
Sponsor
University College Hospital Galway · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Accepted

Summary

Hypertension is a leading risk factor for cardiovascular disease (CVD) globally, accounting for 25-35% of the population-attributable fraction. Sodium (salt) intake is a key determinant of blood pressure, and reducing sodium intake has emerged as an important target for population-based interventions to prevent CVD. However, there is considerable uncertainty about the optimal level of sodium intake that is associated with lowest CV risk, and whether optimal levels differ for different populations and individuals. International and national guidelines recommend low sodium intake (\<2.3g/day, or lower) in all persons, and advocate a population-wide approach to reducing sodium. Most of the world's population (\~95%) consume between 3 and 6g/day of sodium (mean intake 4.0g/day), which means that most people will require a major change to their diet, to achieve the guideline target (\<2g/day). While there is convincing evidence that high sodium intake (\>5g/day) is associated with an increased risk of CVD, compared to low or moderate intake, the evidence that low sodium intake (\<2.0g/day) is associated with a lower risk of CVD than moderate intake (2.0-5g/day) is inconsistent and inconclusive. The investigators plan to conduct a Phase IIb clinical trial to evaluate the role of low sodium intake (versus moderate) on cardiovascular biomarkers.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSodium ReductionIn addition to usual care, those randomised to the intervention arm will receive specific counseling on behavioural and environmental factors that promote sodium reduction after randomization and at all specified post-randomisation visits, targeting sodium intake of \<100mmol/day (\<2.3g/day). A research dietitian will develop the specific components of the intervention, based on standardised approaches to education interventions

Timeline

Start date
2016-04-01
Primary completion
2020-08-01
Completion
2020-08-01
First posted
2016-04-14
Last updated
2021-04-28

Locations

1 site across 1 country: Ireland

Source: ClinicalTrials.gov record NCT02738736. Inclusion in this directory is not an endorsement.